Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergov.uk
News and communications from Medicines and Healthcare products Regulatory Agency (MHRA)
Get the latest updates from News and communications from Medicines and Healthcare products Regulatory Agency (MHRA) directly as they happen.
Follow now 41 followers
Latest posts
Last updated about 17 hours ago
MHRA approves vaccine to protect against pneumococcal infections such as pneumonia and meningitis
about 17 hours ago
As with all products, the MHRA will keep its safety under close...
Meet the women helping ensure that digital mental health technologies are safe, effective and developed considering the needs of the people who use them
3 days ago
Mental health apps are everywhere, offering everything from mood tracking to therapy...
MHRA approves first UK treatment for congenital thrombotic thrombocytopenic purpura (cTTP)
4 days ago
As with all products, the MHRA will keep its safety under close...
MHRA approves world’s first low-carbon version of COPD inhaler Trixeo Aerosphere
4 days ago
As with all medicines, the MHRA will continue to monitor the safety...
MHRA approves teprotumumab as the first UK treatment for adults with moderate to severe Thyroid Eye Disease (TED)
9 days ago
As with all products, the MHRA will keep its safety under close...
Vimkunya vaccine approved to prevent disease caused by the chikungunya virus in people 12 years of age and older
15 days ago
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (1 May...
MHRA authorises cancer treatment variation with an administration time of 3–5 minutes
16 days ago
As with all products, the MHRA will keep its safety under close...
Twelve arrested in MHRA’s biggest ever crackdown on organised medicines trafficking
17 days ago
Dawn raids in four counties across the West Midlands and the Northwest...
Obecabtagene autoleucel conditionally approved to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia
21 days ago
As with all products, the MHRA will keep its safety under close...
Acoramidis approved to treat wild-type or variant transthyretin amyloidosis in adults with cardiomyopathy
21 days ago
As with all products, the MHRA will keep its safety under close...
Patients with asthma reminded of the increased risk of severe asthma attacks from overusing blue inhalers
22 days ago
The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding patients with...
MHRA approves first UK treatment for Friedreich’s ataxia, omaveloxolone
23 days ago
As with all products, we will keep its safety under close review.